Though only a few years old, many previous analyses were outdated and did not reflect more recent findings, such as the cardiovascular benefits of these drugs
Though these drugs have been deemed effective in treating T2DM, the Food and Drug Administration (FDA) and some members of the scientific community have questioned the safety of these therapeutics relative to important cardiovascular endpoints
A similar trial under way at Yale University will follow patients for a year, with data expected in 2028.
[caption id="attachment_5237" align="alignnone" width="660"] The Incretin Effect helps maintain energy homeostasis[/caption] Dipeptidyl Peptidase-4 (DPP-4) Why is GLP-1 so labile
With telehealth providers like Hers, Nurx, Ro, and Alloy, you can book a virtual consultation with a medical provider to learn more about your candidacy and whether or not these weight loss medications are the right option for you